small molecule

DIFFERIN

ADAPALENE

Loss of exclusivityloss of exclusivity
CompanyGALDERMA LABORATORIES LP

Drug detail

Brand nameDIFFERIN
Active ingredientADAPALENE
Strength0.1%
Dosage formCREAM
RouteTOPICAL
ModalitySmall molecule
FDA approvalMay 2000
Marketing statusRX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

DIFFERIN patent cliff — loss of exclusivity — | CliffBio